Royalty Pharma
PTC sells royalty rights of SMA drug Evrysdi to Royalty Pharma for $1.5B
Anika Sharma
As part of its cost-cutting efforts and in response to potential challenges in the European market, PTC Therapeutics is taking ...
Royalty Pharma Pays $150M To Ascendis For A Share Of Skytrofa Sales
Anika Sharma
Royalty Pharma, renowned for its investments in exchange for long-term drug royalties, has entered into a collaboration with Ascendis Pharma ...
Ferring Strikes $500M Agreement with Royalty Pharma for Innovative Bladder Cancer Gene Therapy
Anika Sharma
Royalty Pharma has carved a distinctive niche in the pharmaceutical landscape, specializing in identifying innovative products both pre- and post-approval, ...
